Composition comprising enzymatically hydrolyzed collagen and cannabidiol, the composition suitable for ingestion by an individual to facilitate improvements in rest, including sleep, and/or in recovery, including but not limited to recovery after physical and/or mental exertion, recovery from pain and combinations thereof, and to facilitate improved delivery to the individual of amino acids comprised in the enzymatically hydrolyzed collagen. Both liquid and particulate compositions comprising full spectrum cannabidiol oil or cannabidiol isolate are provided as well as compositions comprising one or more of a terpene isolate, flavonoid, essential oil, effervescent agent, sweetener or flavoring agent.

Composition comprising enzymatically hydrolyzed collagen and cannabidiol, the composition suitable for ingestion by an individual to facilitate improvements in rest, including sleep, and/or in recovery, including but not limited to recovery after physical and/or mental exertion, recovery from pain and combinations thereof, and to facilitate improved delivery to the individual of amino acids comprised in the enzymatically hydrolyzed collagen. Both liquid and particulate compositions comprising full spectrum cannabidiol oil or cannabidiol isolate are provided as well as compositions comprising one or more of a terpene isolate, flavonoid, essential oil, effervescent agent, sweetener or flavoring agent.

A nutraceutical dietary supplement formulation for the treatment of joint pain and discomfort may include astaxanthin powder; boswellia serrate gum resin extract; hyaluronic acid; undenatured type II (UC-II) collagen; eggshell membrane collagen powder; turmeric root extract; white willow bark extract; cayenne pepper extract; and Cat's Claw bark powder. The formulation may be formed into capsules for delivery to a user, wherein a therapeutically effective dosage of the formulation may be included in each capsule.

The present invention relates to collagen hydrolysate for use as an active substance in order to delay the ageing of cells in the bodies of humans or animals.

Provided are compositions comprising a cannabinoid and collagen, and methods of making and using such compositions. The disclosed compositions can be useful in, for example, treating joint pain and inflammation (e.g., joint pain associated with arthritis).

The present invention provides new protease-resistant polypeptides, as well as compositions and methods for treating, ameliorating or preventing conditions related to joint damage, including acute joint injury and arthritis.

An agent of the present invention comprising poultry feet or a processed product thereof, preferably a hydrolysate of an extract of poultry feet, promotes hyaluronic acid production, thereby exhibiting excellent effects of preventing or treating a joint disorder, improving skin dryness, wrinkles or skin tension, moisturizing the skin, etc. The agent is thus useful as a medicament, a quasi-drug, a cosmetic product, a food product or an animal feed.

Compositions comprising a manganese mineral are provided. In specific embodiments, the manganese mineral contains manganese carbonate (MnCO.sub.3), which may be in the form of rhodochrosite. The compositions may be administered topically to a subject, or in some versions by inhalation. For example, the compositions may be administered by direct contact with the subject's skin or by inhalation through the subject's nasal passages or mouth. Such application of the disclosed compositions may increase the subject's collagen synthesis, prolidase activity (an enzyme responsible for collagen function), and manganese superoxide dismutase activity (an antioxidant having manganese in its active site) in the subject.

Compositions comprising a manganese mineral are provided. In specific embodiments, the manganese mineral contains manganese carbonate (MnCO.sub.3), which may be in the form of rhodochrosite. The compositions may be administered topically to a subject, or in some versions by inhalation. For example, the compositions may be administered by direct contact with the subject's skin or by inhalation through the subject's nasal passages or mouth. Such application of the disclosed compositions may increase the subject's collagen synthesis, prolidase activity (an enzyme responsible for collagen function), and manganese superoxide dismutase activity (an antioxidant having manganese in its active site) in the subject.

Colloidal antiseptic compositions for treating wounds and/or for use in surgical operations are provided. The compositions form an elastic air- and water-permeable biodegradable film on the wound surface and have antiseptic, hemostatic, anti-inflammatory, wound-healing, and especially anesthetic and antitoxic effects. The compositions include a collagen hydrolysate, one or more salts of alginic acid and one or more antiseptics, and additionally include unithiol and dimethylsulfoxide. The compositions may also optionally include one or more anesthetics.